Shandong Pharmaceutical Glass Co Ltd
SSE:600529
Shandong Pharmaceutical Glass Co Ltd
Total Equity
Shandong Pharmaceutical Glass Co Ltd
Total Equity Peer Comparison
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Total Equity
¥7.5B
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
14%
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Equity
¥22.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Equity
¥8.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Total Equity
¥11.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Equity
¥7.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Autek China Inc
SZSE:300595
|
Total Equity
¥4.4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
See Also
What is Shandong Pharmaceutical Glass Co Ltd's Total Equity?
Total Equity
7.5B
CNY
Based on the financial report for Mar 31, 2024, Shandong Pharmaceutical Glass Co Ltd's Total Equity amounts to 7.5B CNY.
What is Shandong Pharmaceutical Glass Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
14%
Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for Shandong Pharmaceutical Glass Co Ltd have been 19% over the past three years , 16% over the past five years , and 14% over the past ten years .